|

Intraosseous vs Infiltration Anesthesia in Molar-Incisor Hypomineralization (MIH) Children

RECRUITINGN/ASponsored by Ankara Yildirim Beyazıt University
Actively Recruiting
PhaseN/A
SponsorAnkara Yildirim Beyazıt University
Started2025-11-07
Est. completion2026-11-07
Eligibility
Age6 Years – 12 Years
Healthy vol.Accepted

Summary

This study aims to compare the effectiveness of intraosseous and infiltration anesthesia techniques administered using a computer-assisted anesthesia device (SleeperOne® 5; Dental HiTec, France) during restorative treatments of permanent first molars affected by Molar-Incisor Hypomineralization (MIH) in children. Clinical effectiveness will be evaluated based on the Visual Analogue Scale (VAS), behavioral pain response, pulse rate , salivary chromogranin A levels, and the need for additional anesthesia.

Eligibility

Age: 6 Years – 12 YearsHealthy volunteers accepted
Inclusion Criteria:

* Individuals applying to the Department of Pedodontics, Ankara Yıldırım Beyazıt University Faculty of Dentistry,
* Systemically healthy individuals,
* Individuals without any known allergies,
* Children between the ages of 6 and 12 years,
* Scoring 3-4 according to the Frankl Behavior Rating Scale,
* Children and their legal guardians who, after reading and listening to the informed consent form, fully understand its content and voluntarily provide both verbal and written consent,
* Children with contralateral and homologous maxillary first permanent molars affected by molar-incisor hypomineralization (MIH) and scoring 3-4 according to the MIH Treatment Need Index criteria,
* Children with no emergency treatment needs, such as dental pain,
* Both male and female volunteers.

Exclusion Criteria:

\-

Conditions3

AnxietyHypersensitivityMolar Incisor Hypomineralization

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.